A nutritional supplement containing zinc during preconception and pregnancy increases human milk zinc concentrations
Year: 2023
Type: article
Study design: Clinical Trial
Abstract: Introduction: During pregnancy and lactation minerals such as zinc are required to support maternal and infant health. Zinc is involved in various cellular processes, with requirements increasing in pregnancy and lactation. In the setting of a randomized trial, we investigated the effects on human milk (HM) zinc concentrations of a micronutrient-containing supplement including zinc in the intervention (but not control) group, started preconception and taken throughout pregnancy until birth. Additionally, we characterized longitudinal changes in HM concentrations of zinc and other minerals (calcium, copper, iodine, iron, magnesium, manganese, phosphorus, potassium, selenium, and sodium). Methods: = 180). HM minerals were quantified using sector field inductively coupled plasma mass spectrometry. Potential intervention effects on HM mineral concentrations were assessed using linear mixed models with a repeated measures design and time-weighted area-under-the-curve analyses. Results: = 0.021). Higher HM zinc concentrations were most evident at 6 weeks of lactation. The intervention had no effect on HM concentrations of other minerals, which were not differently supplemented to the control and intervention groups. Temporal changes in HM minerals over 12 months of lactation were studied in the New Zealand mothers; HM zinc and copper concentrations progressively decreased throughout 12 months, while iron, potassium, sodium, and phosphorus decreased until 6 months then plateaued. HM calcium and magnesium initially increased in early lactation and iodine remained relatively constant throughout 12 months. HM manganese and selenium fell over the initial months of lactation, with a nadir at 6 months, and increased thereafter. The contrasting patterns of changes in HM mineral concentrations during lactation may reflect different absorption needs and roles at different stages of infancy. Discussion: Overall, this study indicates that HM zinc concentrations are influenced by maternal supplementation during preconception and pregnancy. Further studies are required to understand the associations between HM zinc and other minerals and both short- and long-term offspring outcomes. Trial registration: ClinicalTrials.gov, identifier: NCT02509988, Universal Trial Number U1111-1171-8056. Registered on 16 July 2015. This is an academic-led study by the EpiGen Global Research Consortium.
Source: Frontiers in Nutrition
Institutions: University of Auckland, Nestlé (Singapore), Uppsala University, Chiang Mai University, Nestlé (China), Nestlé (Switzerland), University Hospital Southampton NHS Foundation Trust, NIHR Southampton Biomedical Research Centre, MRC Lifecourse Epidemiology Unit, University of Southampton, Agency for Science, Technology and Research, National University of Singapore, Singapore Institute for Clinical Sciences, National University Health System
Language: English
Topic: Infant Nutrition and Health
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,295
Funders: New Zealand Government, National Institute for Health and Care Research, British Heart Foundation, University of Southampton, European Commission, National Research Foundation, Agency for Science, Technology and Research, National University of Singapore, Singapore Institute for Clinical Sciences, National Research Foundation Singapore, National University Health System, Medical Research Council, National Medical Research Council
Awards: G103267656, G1321528303, Programme 1: Musculoskeletal health in later life, G1503713314, G1629309755, G1659327504, Children of UPBEAT: a study of cardiovascular function in 10-year-old children of obese women who participated in an antenatal lifestyle intervention, G183778332, G1857620341, G1956390128, G2075874207, G2125390887, Vitamin D supplementation in pregnancy: A systematic review, G2312300077, G2596139817, G2701677525, G2838213439, G3015108477, G3264401604, G3283226014, G3324606240, G3424013768, NIHR Senior Investigator Award, G3446144360, G3552626036, G3637715992, G3772266808, G3873828540, G3883922659, G389277099, G4134451932, G4213458000, G427574963, G4331660922, G434559078, G4387594020, NIHR Senior Investigator Award, Programme 3: Early development and risk of adult musculoskeletal disease, G4964355645, G5061114777, G5068482306, Sarcopenia, Frailty and Clinical Practice in Older People, G5125246644, G5174149251, G5196117068, G5241101149, G5246421578, NIHR Senior Investigator Award, G5285226399, G5318721926, G5435949906, G5741042489, G606602278, G6153309438, G6206044308, G6300410857, Establishment of a National Network on Musculoskeletal Ageing, G645171559, Lifecourse Determinants of Bone and Joint Disease, G6603704606, G6719865625, G6824549163, NIHR Senior Investigator Award, G71336211, G7295670324, G7348633402, G7388601084, G740803340, MRC Lifecourse Epidemiology Centre - Core Support, G7671148335, G7841460102, G7851905008, G7915200173, G8307928819, Nutrition, Development and Lifelong Health: Studies in European Populations, G8537882575, G854637805, G8579916563, G8606453147, G8746938047
OpenAlex ID: W4315647920
